Multimorbidity's research challenges and priorities from a clinical perspective: The case of ‘Mr Curran’

References

• Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3:223–8.
   PubMed Web of Science ®Google Scholar
• Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28:516–23.
   PubMed Web of Science ®Google Scholar
• van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367–75.
   PubMed Web of Science ®Google Scholar
• Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. J Am Med Assoc. 2005;293:1348–58.
   PubMed Web of Science ®Google Scholar
• Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52:1349–54.
   PubMed Web of Science ®Google Scholar
• Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65:130–3.
   PubMed Web of Science ®Google Scholar
• Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–23.
   PubMed Web of Science ®Google Scholar
• Campbell-Scherer D. Multimorbidity: A challenge for evidence-based medicine. Evid Based Med. 2010;15:165–6.
   Google Scholar
• Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. J Am Med Assoc. 2005;294:716–24.
   PubMed Web of Science ®Google Scholar
• Tinetti ME, Bogardus ST, Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870–4.
   PubMed Web of Science ®Google Scholar
• Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: A systematic review. Health Qual Life Outcomes. 2004;2:51.
   PubMedGoogle Scholar
• Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois MF, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006; 15:83–91.
   PubMed Web of Science ®Google Scholar
• Fortin M, Bravo G, Hudon C, Lapointe L, Dubois M-F, Almirall J. Psychological distress and multimorbidity in primary care. Ann Fam Med. 2006;4:417–22.
   PubMed Web of Science ®Google Scholar
• Glynn LG, Buckley B, Reddan D, Newell J, Hinde J, Dinneen SF, et al. Multimorbidity and risk among patients with established cardiovascular disease: A cohort study. Br J Gen Pract. 2008;58:488–94.
   Google Scholar
• Thorpe KE, Howard DH. The rise in spending among Medicare beneficiaries: The role of chronic disease prevalence and changes in treatment intensity. Health Aff (Millwood). 2006;25:w378–88.
   Web of Science ®Google Scholar
• Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–76.
   PubMed Web of Science ®Google Scholar
• Heath I, Rubinstein A, Stange KC, van Driel ML. Quality in primary health care: a multidimensional approach to complexity. Br Med J. 2009;338:b1242.
   Web of Science ®Google Scholar
• Plsek PE, Greenhalgh T. Complexity science: The challenge of complexity in health care. Br Med J. 2001;323:625–8.
   PubMed Web of Science ®Google Scholar
• Bodenheimer TS, Berry-Millett R. Care management of patients with complex health care needs. Synth Proj Res Synth Rep. 2012;pii:52372.
   Google Scholar
• Valderas JM, Mercer SW, Fortin M. Research on patients with multiple health conditions: Different constructs, different views, one voice. J Comorbidity. 2011;1:1–3.
   Google Scholar
• Arksey H, O’Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.
   Google Scholar
• Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med. 2012;10:142–51.
   PubMed Web of Science ®Google Scholar
• Valderas JM, Glynn LG, Ferrer-Menduina X, Johnson R, Salisbury C. Multi-morbidity, rule or exception? A systematic review and meta-regression of prevalence studies of multi-morbidity. Fam Med. 2011;43(Suppl. 1). Available at http://www.stfm.org/fmsup/napcrg/fmconferencesupplement.cfm?confid = 135 (accessed 3 June 2013).
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
   PubMedGoogle Scholar
• Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–6.
   PubMed Web of Science ®Google Scholar
• von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.
   PubMed Web of Science ®Google Scholar
• Freitag M, Quinzler R, Beyer M, Dahlhaus A, Doering A, Freund T, et al. Diagnosenselektion für einen neuen medikationsbasierten. Chronic Disease Score (BMBF-FZ: 01ET1004B). Available at http://www.egms.de/static/en/meetings/fom2011/11fom095.shtml (accessed 3 June 2013).
   Google Scholar
• Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357–63.
   PubMed Web of Science ®Google Scholar
• van den Akker M, Vos R, Knottnerus JA. In an exploratory prospective study on multimorbidity general and disease-related susceptibility could be distinguished. J Clin Epidemiol. 2006;59:934–9.
   Google Scholar
• van Weel C, Schellevis FG. Comorbidity and guidelines: Conflicting interests. Lancet 2006;367:550–1.
   PubMed Web of Science ®Google Scholar
• Lanzer P, Zuehlke H, Jehle P, Silber RE. Cardiovascular multimorbidity, emerging coalescence of the integrated panvascular approach. Z Kardiol. 2004;93:259–65.
   Google Scholar
• Glynn LG, Reddan D, Newell J, Hinde J, Buckley B, Murphy AW. Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: A West of Ireland community-based cohort study. Nephrol Dial Transplant 2007;22:2586–94.
   Google Scholar
• Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.
   PubMed Web of Science ®Google Scholar
• Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med. 1998;15:53–9.
   PubMed Web of Science ®Google Scholar
• Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69–75.
   PubMed Web of Science ®Google Scholar
• Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 2002;25:43–8.
   PubMedGoogle Scholar
• McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847.
   PubMed Web of Science ®Google Scholar
• Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database of Syst Rev. 2012:CD006560.
   Google Scholar
• Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011:CD001800.
   Google Scholar
• Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011:CD000333.
   Google Scholar
• Kanning M, Schlicht W. A bio-psycho-social model of successful aging as shown through the variable ‘physical activity’. Eur Rev Aging Phys Act. 2008;5:79–87.
   Google Scholar
• Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database of Syst Rev. 2009:CD00432009.
   Google Scholar
• Harkness E, Macdonald W, Valderas J, Coventry P, Gask L, Bower P. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: A systematic review and meta-analysis. Diabetes Care. 2010;33:926–30.
   PubMed Web of Science ®Google Scholar
• Cooper A, O’Flynn N. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: Summary of NICE guidance. Br Med J. 2008;336:1246–8.
   PubMed Web of Science ®Google Scholar
• Sanz G, Fuster V. Fixed-dose combination therapy and secondary cardiovascular prevention: Rationale, selection of drugs and target population. Nat Clin Pract Cardiovasc Med. 2009;6:101–10.
   PubMedGoogle Scholar
• Tsai AC, Morton SC, Mangione CM, Keeler EB. A meta-analysis of interventions to improve care for chronic illnesses. Am J Manag Care 2005;11:478–88.
   PubMed Web of Science ®Google Scholar
• Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: Translating evidence into action. Health Aff (Millwood). 2004;20:64–78.
   Google Scholar
• Morris RL, Sanders C, Kennedy AP, Rogers A. Shifting priorities in multimorbidity: A longitudinal qualitative study of patient’s prioritization of multiple conditions. Chronic Illn. 2011;7:147–61.
   PubMedGoogle Scholar
• Freund T, Wensing M, Mahler C, Gensichen J, Erler A, Beyer M, et al. Development of a primary care-based complex care management intervention for chronically ill patients at high risk for hospitalization: A study protocol. Implement Sci. 2010;570.
   Google Scholar
• Campbell SE, Seymour DG, Primrose WR, Lynch JE, Dunstan E, Espallargues M, et al. A multi-centre European study of factors affecting the discharge destination of older people admitted to hospital: Analysis of in-hospital data from the ACMEplus project. Age Ageing. 2005;34:467–75.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49:209.
   Google Scholar
• Thomson LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007;41:1411–26.
   Google Scholar
• Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS One 2009;4:e4439.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. Br Med J. 2004; 329:15–9.
   PubMed Web of Science ®Google Scholar
• Crooks J. Rational therapeutics in the elderly. J Chronic Dis. 1983;36:59–65.
   Google Scholar
• Steinman MA, Hanlon JT. Managing medications in clinically complex elders: ‘There’s got to be a happy medium’. J Am Med Assoc. 2010;304:1592–601.
   PubMed Web of Science ®Google Scholar
• Vestal RE. Drug use in the elderly: A review of problems and special considerations. Drugs 1978;16:358–82.
   PubMed Web of Science ®Google Scholar
• Vestal RE. Aging and pharmacology. Cancer 1997;80: 1302–10.
   PubMed Web of Science ®Google Scholar
• Schaeffer D, Mueller-Mundt G, Haslbeck J. Bewältigung komplexer Medikamentenregime bei chronischen Erkrankungen—Herausforderungen aus Sicht der Gesundheitsprofessionen. Veroeffentlichungsreihe des Instituts für Pflegewissenschaft an der Universität Bielefeld (IPW), P07–134 2007. Avaliable at http://www.uni-bielefeld.de/gesundhw/ag6/downloads/ipw-134.pdf (accessed 3 June 2013).
   Google Scholar
• Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: The consequences for concordance. Health Expect. 2004;7:235–45.
   PubMed Web of Science ®Google Scholar
• Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: The new Medical Research Council guidance. Br Med J. 2008; 337:a1655.
   PubMed Web of Science ®Google Scholar
• Perera R, Heneghan C, Yudkin P. Graphical method for depicting randomised trials of complex interventions. Br Med J. 2007;334:127–9.
   PubMed Web of Science ®Google Scholar
• Yudkin P, Perera R, Glasziou P. Complexity of the intervention, in randomized clinical trials of nonpharmacological treatments. In: Boutron I, Ravaud P, Moher D, editors. Randomized clinical trials of nonpharmacological treatments. Boca Raton: CRC Press; Taylor & Francis Group; 2012. pp. 27–42.
   Google Scholar
• Mollenkopf H, Walker A. Quality of life in old age - international and multi-disciplinary perspectives. Social Indicators Research Series, 2007.
   Google Scholar
• Lawton MP, Moss M, Hoffman C, Kleban MH, Ruckdeschel K, Winter L. Valuation of life: A concept and a scale. J Aging Health 2001;13:3–31.
   PubMed Web of Science ®Google Scholar
• Meropol NJ, Egleston BL, Buzaglo JS, Benson AB, III, Cegala DJ, Diefenbach MA, et al. Cancer patient preferences for quality and length of life. Cancer. 2008;113:3459–66.
   PubMed Web of Science ®Google Scholar
• Vernooij-Dassen MJ, Osse BH, Schade E, Grol RP. Patient autonomy problems in palliative care: Systematic development and evaluation of a questionnaire. J Pain Symptom Manage. 2005;30:264–70.
   Web of Science ®Google Scholar
• Hills P, Argyle M. The Oxford happiness questionnaire: A compact scale for the measurement of psychological well-being. Pers Individ Dif. 2002;33:1073–82.
   Web of Science ®Google Scholar
• Gensichen J, Serras A, Paulitsch MA, Rosemann T, Koenig J, Gerlach FM, et al. The patient assessment of chronic illness care questionnaire: Evaluation in patients with mental disorders in primary care. Community Ment Health J. 2011;47:447–53.
   Google Scholar
• Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the patient assessment of chronic illness care (PACIC). Med Care. 2005;43: 436–44.
   PubMed Web of Science ®Google Scholar
• Goetz K, Freund T, Gensichen J, Miksch A, Szecsenyi J, Steinhaeuser J. Adaptation and psychometric properties of the PACIC short form. Am J Manag Care 2012;18:e55–60.
   Google Scholar
• Hickey A, Barker M, McGee H, O’Boyle C. Measuring health-related quality of life in older patient populations: A review of current approaches. Pharmacoeconomics. 2005; 23:971–93.
   PubMed Web of Science ®Google Scholar
• Power M, Quinn K, Schmidt S. Development of the WHOQOL-old module. Qual Life Res. 2005;14:2197–214.
   PubMed Web of Science ®Google Scholar
• Baltes PB. On the incomplete architecture of human ontogeny. Selection, optimization, and compensation as foundation of developmental theory. Am Psychol. 1997;52:366–80.
   PubMed Web of Science ®Google Scholar
• Lawton MP. Three functions of the residential environment. In: Pastalan L, Cowart M, editors. Lifestyle and housing of older adults: The Florida experience. New York: The Haworth Press; 1989. pp. 39–50.
   Google Scholar
• Wahl H-W, Mollenkopf H, Oswald F, Claus C. Environmental aspects of quality of life in old age: Conceptual and empirical issues. In: Mollenkopf H, Walker A, editors. Quality of life in old age—international and multidisciplinary perspectives. Dordrecht: Springer; 2007. pp. 101–22.
   Google Scholar
• Wahl H-W, Oswald F. Environmental perspectives on aging. In: Dannefer D, Phillipson, C, editors. International handbook of social gerontology. London: London; 2010. pp. 111–24.
   Google Scholar
• Wahl HW, Iwarsson S, Oswald F. Aging well and the environment: Toward an integrative model and research agenda for the future. Gerontologist. 2012;52:306–16.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.
   PubMed Web of Science ®Google Scholar
• Bregnhoj L, Thirstrup S, Kristensen MB, Bjerrum L, Sonne J. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol. 2009;65:199–207.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428–37.
   PubMed Web of Science ®Google Scholar
• Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–82.
   PubMed Web of Science ®Google Scholar
• Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877–83.
   PubMed Web of Science ®Google Scholar
• Emsley R, Dunn G, White IR. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res. 2010;19:237–70.
   PubMed Web of Science ®Google Scholar
• Kernick D. A theoretical framework for multimorbidity: From complicated to chaotic. Br J Gen Pract. 2012;62:659–62.
   Google Scholar
• Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CFB, Marteau T. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2:188.
   Google Scholar
• Walker AE, McLeer SK. Small group processes relevant to data monitoring committees in controlled clinical trials: An overview of reviews. Clin Trials 2004;1:282–96.
   Google Scholar